|
Disease activity score using 28-joint counts including CRP (DAS28)
|
2.1 ± 0.3 (1.21–2.6)
|
1.9 ± 0.3 (1.01–2.59)
|
P <0.01
|
1.8 ± 0.28 (1.21–2.72)
|
1.7 ± 0.2 (1.21–2.72)
|
P <0.01
|
|
Simplified disease activity index (SDAI)
|
4.3 ± 2.8 (0.3–16.1)
|
3.2 ± 2.5 (0.1–18.2)
|
P <0.01
|
1.9 ± 0.9 (0.1–3.3)
|
1.3 ± 0.8 (0.1–3.24)
|
P <0.01
|
|
Health assessment questionnaire (HAQ)
|
0.28 ± 0.4 (0–2.25)
|
0.20 ± 0.4 (0–1.92)
|
P <0.01
|
0.15 ± 0.3 (0–2.25)
|
0.11 ± 0.3 (0–1.75)
|
P <0.01
|
|
Swollen joint count 28 joints (SJC28)
|
1.3 ± 2.2 (0–15)
|
0.8 ± 2.0 (0–17)
|
P <0.01
|
0.3 ± 0.5 (0–2)
|
0.2 ± 0.4 (0–2)
|
P <0.01
|
|
Tender joint count 28 joints (TJC28)
|
0.4 ± 0.7 (0–3)
|
0.2 ± 0.5 (0–3)
|
P <0.01
|
0.2 ± 0.5 (0–2)
|
0.1 ± 0.4 (0–2)
|
P <0.01
|
|
Visual analogue scale for pain (VAS pain in mm)
|
8.8 ± 10.9 (0–80)
|
6.9 ± 8.5 (0–64)
|
P <0.01
|
4.4 ± 6.1 (0–53)
|
3.0 ± 4.0 (0–24)
|
P <0.01
|
|
Patient global assessment of disease activity (PGA in mm)
|
11 ± 11.8 (0–70)
|
8.8 ± 9.6 (0–57)
|
P <0.01
|
4.5 ± 5.4 (0–27)
|
3.5 ± 4.9 (0–30)
|
P <0.01
|
|
Evaluator global assessment of disease activity (EGA in mm)
|
10.2 ± 10.3 (0–92)
|
7.7 ± 8.9 (0–93)
|
P <0.01
|
4.4 ± 4.7 (0–24)
|
3.1 ± 3.7 (0–17)
|
P <0.01
|
|
C-reactive protein (CRP, mg/dL)
|
0.50 ± 0.6 (0.1–9.4)
|
0.52 ± 0.5 (0.1–4.3)
|
P = 0.46
|
0.49 ± 0.4 (0.1–2.92)
|
0.50 ± 0.4 (0.1–3.8)
|
P = 0.69
|
